Institutional investors purchased a net $1.7 million shares of TGTX during the quarter ended June 2019, and now own 74.79% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 2.9 Million shares of TG Therapeutics Inc
CAPITAL RESEARCH & MANAGEMENT CO... Bought 2.3 Million shares of TG Therapeutics Inc